All patients also received a course of primaquine (15 mg/d for 14 days) to avoid malarial relapse, none having a glucose-6-phosphate-dehydrogenase (G6PD) deficiency. Here, G6PD is linked to hyperinsulinemic hypoglycemia, familial, 4.